Defective visual perception in patients with Lewy body disease: assessment of hallucinations with pareidolia test.
Objective: Hallucination is a common feature in patients with advanced Parkinson’s disease(PD) and dementia with Lewy bodies (DLB). Background: The pareidolia test is a tool…Feasibility, tolerability and acceptance of a psychosocial intervention for people with Parkinsonian dementia: The INVEST trial.
Objective: To compare a companion-guided, home-delivered psychosocial stimulation intervention to treatment as usual (TAU) to inform a large-scale efficacy trial for people with cognitive impairment…A new psychosocial intervention for people with Parkinsonian dementias: Adherence, barriers and facilitators
Objective: To investigate participant adherence and engagement to a home-based, companion-guided cognitive stimulation therapy adapted for people with Parkinsonian dementias (CST-PD). Background: Adherence to rehabilitation…Do Acetylcholinesterase Inhibitors (AChEI) delay institutionalisation in Parkinson’s and Lewy Body Disease?
Objective: We explored the use of Rivastigmine in Parkinson’s and Lewy body dementia through assessment of quantitative data obtained from a clinical database. We focussed…Glucocerebrosidase mutations in neurodegenerative disorders other than Parkinson’s disease
Objective: To determinate the frequencies of lysosomal glucocerebrosidase (GBA) common mutations in a large sample of neurodegenerative diseases including Alzheimer Disease (AD), Lewy Body Dementia (LBD), Amyotrophic…Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.
Objective: We report two patients with Parkinson’s disease(PD) and Capgras syndrome (CS) with confusion of identify not just of close acquaintances but also of “self”.…A Phase 2 Study of Nelotanserin, a Novel 5HT2A Receptor Inverse Agonist, in Dementia with Lewy Bodies and Parkinson’s Disease Dementia Subjects Experiencing Visual Hallucinations
Objective: To evaluate the safety and efficacy of nelotanserin in Lewy body dementia subjects experiencing visual hallucinations. Background: Nelotanserin is a selective 5HT2A receptor inverse…Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments
Objective: We compared quantitative susceptibility mapping (QSM) values in the hippocampi among patients with Parkinson disease (PD) and PD with dementia (PDD)/ Lewy body dementia…Causes, Complications and Outcomes of Hospitalization in Patients with Dementia with Lewy Bodies
Objective: To identify causes, complications and outcomes of hospitalization in patients with dementia with Lewy bodies (DLB). Background: Hospitalization is a known contributor to morbidity…Parkinson’s disease with visual hallucination: optic radiation abnormalities on phase difference-enhanced imaging (PADRE)
Objective: We assessed structural abnormalities of optic radiation (OR) in patients with Parkinson disease (PD) with dementia (PDD) and dementia with lewy bodies (DLB) by…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- 23
- Next Page »